Glide Pharmaceutical Technologies
Abingdon
About Glide Pharmaceutical Technologies
Glide Pharmaceutical Technologies is a clinical stage development company that focuses on solid dose formulations of therapeutics and vaccines. The company develops SDI, a solid dose injector system to improve compliance in patients self-administering long term therapy. Its pipeline of solid dose formulations includes octreotide, teriparatide, and anthrax and influenza vaccines. Glide Pharmaceutical Technologies was formerly known as Caretek Medical.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $37.8M
- Last round: Series Unknown (Feb 2017)
- Website: glide-technologies.com
- Phone: +44 8700 853 700
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/glide-pharmaceutical-technologies-123358 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.